
Keywords: گذار اپیتلیال به مزانشیمال; CAFs; cancer-associated fibroblasts; CLCs; CAF-like cells; EMT; epithelial-to-mesenchymal transition; FDR; false discovery rate; IRDS; interferon-related DNA damage resistance signature; LC; liquid chromatography; LFQ; label free quantification; MRM; mult